Targeting the cannabinoid system to counteract the deleterious effects of stress in alzheimer`s disease

HIGHLIGHTS

SUMMARY

    This presents a reckoning of the predated, yet commonly used diagnosis of AD based on the NINCDS-ADRDA criteria to incorporate earlier onset AD symptoms without being limited to ruling-in dementia during the first step approach (McKhann et_al, 1984; Dubois et_al, 2007; Sutphen et_al, 2014; Cece and Shifu, 2015). A culmination of neuroimaging and genomic evidence suggests significant neurobiological differences distinguish BPSD patients from those that do not exhibit psychiatric symptoms (Klimek et_al, 1997; Ordway et_al, 1997, 2003; McCulley et_al, 2004; Szot et_al, 2006; Borroni et_al, 2009; Grunblatt et_al, 2009; Combarros et_al, 2010 . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?